Literature DB >> 20007752

Carotid endarterectomy benefits patients with CKD and symptomatic high-grade stenosis.

Anna Mathew1, Michael Eliasziw, P J Devereaux, Jose G Merino, Henry J M Barnett, Amit X Garg.   

Abstract

Endarterectomy is generally recommended for symptomatic high-grade (70 to 99%) stenosis of the internal carotid artery, but whether this procedure is beneficial among patients with chronic kidney disease (CKD) is unknown. In this re-analysis of data from the North American Symptomatic Carotid Endarterectomy Trial, we included patients with symptomatic stenosis and either stage 3 CKD (n = 524) or preserved kidney function (n = 966; estimated GFR > or = 60). For medically treated patients with high-grade stenosis, risk for ipsilateral stroke at 2 yr was significantly higher in patients with CKD than in those with preserved renal function (31.6 versus 19.3%; P = 0.042); carotid endarterectomy significantly reduced this risk by 82 and 51%, respectively. To prevent one ipsilateral stroke, the number needed to treat by endarterectomy was four for patients with CKD and 10 for patients with preserved renal function. Compared with patients with preserved renal function, those with CKD had similar rates of perioperative stroke and death but higher rates of cardiac events. In conclusion, patients with stage 3 CKD and symptomatic high-grade carotid stenosis gain a large benefit in stroke risk reduction after endarterectomy.

Entities:  

Mesh:

Year:  2009        PMID: 20007752      PMCID: PMC2799271          DOI: 10.1681/ASN.2009030287

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  39 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  A consumer's guide to subgroup analyses.

Authors:  A D Oxman; G H Guyatt
Journal:  Ann Intern Med       Date:  1992-01-01       Impact factor: 25.391

3.  Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST)

Authors: 
Journal:  Lancet       Date:  1998-05-09       Impact factor: 79.321

4.  Simulation study of confounder-selection strategies.

Authors:  G Maldonado; S Greenland
Journal:  Am J Epidemiol       Date:  1993-12-01       Impact factor: 4.897

5.  Subgroup interactions in the Heart and Estrogen/Progestin Replacement Study: lessons learned.

Authors:  Curt D Furberg; Eric Vittinghoff; Michael Davidson; David M Herrington; Joel A Simon; Nanette K Wenger; Stephen Hulley
Journal:  Circulation       Date:  2002-02-26       Impact factor: 29.690

6.  "Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency.

Authors:  Glenn M Chertow; Sharon-Lise T Normand; Barbara J McNeil
Journal:  J Am Soc Nephrol       Date:  2004-09       Impact factor: 10.121

7.  Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis.

Authors:  H J M Barnett; D W Taylor; R B Haynes; D L Sackett; S J Peerless; G G Ferguson; A J Fox; R N Rankin; V C Hachinski; D O Wiebers; M Eliasziw
Journal:  N Engl J Med       Date:  1991-08-15       Impact factor: 91.245

8.  Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study.

Authors: 
Journal:  JAMA       Date:  1995-05-10       Impact factor: 56.272

9.  Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators.

Authors:  H J Barnett; D W Taylor; M Eliasziw; A J Fox; G G Ferguson; R B Haynes; R N Rankin; G P Clagett; V C Hachinski; D L Sackett; K E Thorpe; H E Meldrum; J D Spence
Journal:  N Engl J Med       Date:  1998-11-12       Impact factor: 91.245

10.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors:  L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321

View more
  3 in total

Review 1.  Atherosclerosis in CKD: differences from the general population.

Authors:  Tilman B Drüeke; Ziad A Massy
Journal:  Nat Rev Nephrol       Date:  2010-10-26       Impact factor: 28.314

Review 2.  Stroke in Patients with Chronic Kidney Disease…: How do we Approach and Manage it?

Authors:  S Nayak-Rao; M P Shenoy
Journal:  Indian J Nephrol       Date:  2017 May-Jun

3.  Modulation of stroke risk in chronic kidney disease.

Authors:  Julia Arnold; Don Sims; Charles J Ferro
Journal:  Clin Kidney J       Date:  2015-12-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.